Inogen grows sales 13% in Q3
Inogen (Nasdaq:INGN) this week posted third-quarter results that beat the overall consensus on Wall Street.
Stay updated with breaking news from Massdevice Medtech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Inogen (Nasdaq:INGN) this week posted third-quarter results that beat the overall consensus on Wall Street.
Johnson & Johnson has made its move on M&A, announcing today that it will acquire Abiomed for approximately $16.6 billion.
Axonics (Nasdaq:AXNX) shares took a hit after hours despite third-quarter results that bettered the consensus forecast.
Hologic (Nasdaq:HOLX) shares ticked up after hours today on fourth-quarter results that came in well ahead of the consensus forecast.
Bio-Rad shares took a hit on third-quarter results that came in mixed compared to the consensus forecast.